chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Runny nose; Stuffy nose; Sniffles; allergy-like symptoms; A spontaneous report was received from a consumer concerning herself, age not provided, a female patient who received Moderna's COVID-19 vaccine and experienced runny nose, sniffles, stuffy nose and allergy-type symptoms.  The patient's medical history was not provided. Products known to have been used by the patient, within two weeks prior to the event, were not provided.   On 04 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Lot number: unknown) for prophylaxis of COVID-19 infection.    On 04 Jan 2021, after she received the mRNA-1273 vaccination, patient experienced a runny nose, sniffles, stuffy nose and allergy-type symptoms. Treatment information was not provided. Patient reports that these symptoms resolved on 05 Jan 2021.  On 06 Jan 2021, the patient reports that the same symptoms returned. No treatment information was provided. Action taken with the second dose of mRNA-1273 in response to the event was not reported.    The outcome of the events, runny nose, sniffles, stuffy nose was not recovered and allergy-type symptoms was not provided.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Approx 1015 vax given; walked home 1040 mom noticed c/o coldness, vomited up some clear H20; back to clinic rapid shallow respirations, pale, shivering, p120, wheezing;
worsening fatigue after the second dose; This is a spontaneous report from a contactable consumer or other non hcp.A 41-years-old female patient received bnt162b2 (BNT162B2, Pfizer-Biontech Covid-19 Vaccine, Solution for injection, Batch/Lot Number: EN5318), dose 2 via an unspecified route of administration, administered in left arm on 01Feb2021 18:00 (at 41-years-old) as single dose for Vaccination. The patient medical history was not reported and had not received other products. There was no Prior Vaccinations (within 4 weeks). There was no adverse events following prior vaccinations. There was no History of all previous immunization with the Pfizer vaccine considered as suspect and no Additional Vaccines Administered on Same Date of the Pfizer Suspect. Concomitant medications included metoprolol ongoing from an unspecified date (12.5 mg, 1x/day) for an unspecified indication (Been on it for years never had any trouble). The patient previously received bnt162b2 (BNT162B2, Pfizer-Biontech Covid-19 Vaccine, Solution for injection, Batch/Lot Number: EL1283), dose 1 via an unspecified route of administration, administered in left arm on 11Jan2021 as single dose for Vaccination. On 02Feb2021, at 11:00 the patient experienced worsening fatigue after the second dose. It was reported that the patient was administered her second dose of Pfizer COVID-19 Vaccine 01Feb2021 at 18:00 and felt great afterwards. She started to have some fatigue 02Feb2021 around 11:00. She called to ask if it was normal for fatigue to go on this long and to worsen. On 04Feb2021, the patient was not admitted in hospital, but under observation in Emergency room for event fatigue and has not resulted in Physician Office. She reported that she might had a tiny scratch in her throat a couple of days before onset of fatigue, but it was very minor. The patient daughter had a little runny nose, so she was tested and was positive for Rhinovirus; not COVID; the patient assumed she may have gotten a little bit of her rhinovirus but she did not even develop stuffy nose; just a tiny scratch or tickle in her throat. Laboratory tests performed on 04Feb2021 in emergency room included Chest X- ray: showed nothing; full blood count (CBC): all normal and Basic Metabolic Panel-test, Result: normal; Mono: negative; tested for any respiratory illnesses in her nose: none, all normal. They sent her home from emergency room. Outcome of the event was reported as not recovered.  Follow-up (05Feb2021): Upon follow up, new information included: relevant lab tests, concomitant medication details, patient details.  No follow-up attempts are possible and no further information is expected.
presented to ED with complaints of shortness of breath.  Initially patient diagnosed with pneumonia due to possible right-sided infiltrate on CT angio.  Patient was discharged home with oral antibiotics.  She was contacted when repeat troponin was elevated with concern for NSTEMI.  She returned to the hospital and stat echocardiogram was ordered and Lasix given. Decision was made to treat with medical therapy including beta-blocker and statin.  ED visit and hospital admission within 6 weeks of receiving the COVID vaccine.
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 80-year-old female patient who received Shingrix for prophylaxis. On 19th May 2018, the patient received the 1st dose of Shingrix (intramuscular). On 20th May 2018, 1 days after receiving Shingrix, the patient experienced injection site pain, injection site erythema and injection site swelling. On an unknown date, the outcome of the injection site pain, injection site erythema and injection site swelling were recovered/resolved. It was unknown if the reporter considered the injection site pain, injection site erythema and injection site swelling to be related to Shingrix. Additional details were provided as follows: The patient received Shingrix in the left arm and on the next day the patient experienced a little redness, swelling and soreness at injection site (left arm). The patient was unsure how long these symptoms lasted. For the tolerance of 2nd dose, refer linked to the case US2018164488, reported by the same reporter for the same patient.
5 days  after  2nd Vaccine my entire body  and face covered my red painful sometimes very itchy rash. Started steroids on Friday so far little improvement.
I woke up next morning heart racing pulse was 94 resting heart rate usually 60. Throughout the day my heart rate went up to 120 which is abnormal for me. I contacted my PCP was told to take Benadryl and rest maybe anxiety. Then went to office visit heart rate was still elevated given holter monitor to wear 48n hrs.
No side effects until 3-4hrs after the shot. Then headache, fatigue, fever, body aches for approx. 48hrs afterwards
Resident observed shirtless sitting in wheelchair with 02 @ 2L/M via NC in progress, using substernal accessory muscles, flared nostrils, pursed lip breathing. Alert verbally responsive, unable to speak more than 2-3 words at a time. Reports " I cant breathe". R 30 P 100 02 Sat 89%. Rebreather mask administered, and EMS initiated and transferred patient to emergency room, where he was admitted for respiratory failure.
While administering second dose of Moderna vaccine patient reported immediate post vaccination feelings of chest pressure and difficulty breathing and feeling faint. Respirations are Shallow and even. Nurses supported patient in chair. Patient moved to cott. On-site medical staff arrived while code green was called. Vital  signs taken patient refused  additional blood sugar check patient refused to be transported for emergency services no additional measures needed right now. patient stable and walking to observation.
Pt returned to ER on 4/2/2000, post vax, with cellulitis in right upper extremity. Pt was then admitted to the hospital on 4/2/2000. Pt was treated with Ancef. Pt was afebrile and discharged on 4/3/2000.
Severe urticaria, papular rash. Full body itchy, warm, red rash. Prescribed Tagamet,Benadryl and Prednisone 2 days after vaccination. Rash has only been getting worse each day.
1AM 6MAY98 woke up w/severe n, restless, tossing & turning;vomiting;returned to bed, body tingling & chills for next 3hr;severe low back pain;from 9AM to evening;extreme weakness & fatigue;syncope, vertigo;constipation
I was a very healthy 59 year old man who is slim and in good shape 5'9" 162 lbs I worked out 3 times a week and did 2 sets of 15 pushups 3 times a week for the last 10 years. I have been on a downward trend since getting the first vaccine. Horrible pain in my right shoulder that radiates up towards my neck. Shooting nerve pains down my left leg and have felt extreme fatigue and have a dull headache every day. Shortly after getting the vaccine I got slight bronchitis. I also think the shot was administer too high I have severe pain in my right shoulder and have MRI scheduled on that. I have went from a guy that did 90 push ups a week to one that can't complete 1 push up due to the pain in my shoulder. I feel as though I have been poisoned.
Vaccine stored in immunization refrigerator from deep freeze state on July 20, 2021. Vaccine administered on August 30, 2021 which exceeds recommended storage time. Vaccine vial expiration was August 31, 2021. Client with NO adverse reactions noted.
Pain in the right forearm, upper shoulder and the pain in the joints. The arm feels numb.
On March 15, approximately 20 hours post 2nd dose I developed diarrhea and what I thought were hemorrhoids, and felt generally unwell with severe fatigue . On March 17 my A_Fib became active and I was electrically converted on March 19. The diarrhea persisted until March 20-21. I improved until March 26 and my A-Fib returned, and was successfully converted 29 March. This is unusual for me. Cardioversion  works and I remain a-fib free for years before A-fib returns.  The last previous episode of A-fib was in February 2020, one day after a severe viral infection which persisted for app 36 hours. I was tested and it was not COVID nor flu. It seems the inflammatory state caused by a viral infection or the inflammatory response caused by the second dose of vaccine affects my heart to the point it induces A-Fib. I am not a teenage boy, but it seems like this could be the same type of cardiomyopathy (induced by TNF???).
EVENTS December 10, 2009 o Took shingles vaccine December 19/20 o Minor neck pain when lying in bed December 23 o Severe neck pain (for 15 minutes) when lying in bed o Came and stopped suddenly December 24/25 o Numbness in left hand and arm,  reduced motor skills and sensitivity to cold & hot o Limp when walking, but no pain or resistance o Minor neck pain continues December 26 o Symptoms continue o Intense neck pain for a 1 hour period o Skin on left neck/shoulder area is very sensitive December 27-30 o Symptoms continue o No intense pain o Visit Dr. (family) on December 30 o Took neck x-rays o Prescribed MRI December 31 o Symptoms continue o MRI at Hospital o 1st MRI of neck o  Called back for MRI of brain o Referred to Dr.  January 1-5, 2010 o Symptoms continue o Limp disappears o No intense pain in neck January 6 o Met Dr. who examined 1st MRI o Another MRI  full spine o Prescribed steroid pack (6-day) January 7-14 o Symptoms continue (no limp) o Skin sensitivity in neck/shoulder ends o Dr. responds on Jan 14 to get opinions and treatment from experts January 19 o Symptoms begin getting slightly less intense o Begin having more functionality in fingers and arm o Met with Dr.  January 22 o Dr's office called o Prescribed Valtrex (3-day) o Suggested another MRI in near future January 23-25 o No intense neck pain o Completed Valtrex on 1/25/10 o Numbness and use of left arm/hand have improved significantly (50+% improvement) January 26 o Met with Drs.  o Eliminated likeliness of ependymoma and cancer o Suggested returning to UAB for further diagnosis and treatment as needed January 27 - February 2 o Symptoms on left arm/hand continue to improve and stabilize at 80% improvement level.   February 3-7  o Begin to notice brief (2-second) sensations in right leg, arm and hand.  Not the same numbness, but hard to describe. Occurs several times per day on Feb 3&4, and less often on Feb 5-7 o Also noticed that the slight pain in my neck came back on Feb 3&4.
Headache, Myalgia, Arthralgia, decreased appetite, general malaise, some abdominal discomfort
Sore lymph node on left collarbone; Swollen lymph node on left collarbone; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 05Apr2021 at 14:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high. Patient had no known allergies to medications, food or other products. Concomitant medications included lisinopril dihydrate (LISINOPRIL), venlafaxine hydrochloride (EFFEXOR), norgestimate (ORTHO CYCLEN) for unknown indication, from unknown dates and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 07Apr2021 the patient experienced sore lymph node on left collarbone and swollen lymph node on left collarbone. No therapeutic measures were not taken as a result of reported events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event sore lymph node and swollen lymph node on left collarbone was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Discharge Provider: MD Primary Care Provider:  MD Admission Date: 4/6/2023 Discharge Date: Apr 11, 2023  PRESENTING PROBLEM: Respiratory failure with hypoxia (HCC) Pneumonia of right lung due to infectious organism, unspecified part of lung   HOSPITAL COURSE: Patient is an 82-year-old woman with past medical history significant for stage II squamous cell carcinoma of the lung status post radiation therapy, severe aortic stenosis status post TAVR, chronic obstructive pulmonary disease, paroxysmal atrial fibrillation, and heart failure preserved ejection fraction who was admitted on 04/06 for acute hypoxic respiratory failure secondary to multifocal pneumonia. She was placed on 2L NC and started IV antibiotics with cefepime and azithromycin. She developed diarrhea on antibiotics and ID was consulted as she had recent history of indeterminate C. Diff infection with oral vancomycin treatment.  Her C difficile came back indeterminate, Infectious Disease recommended start the patient on oral vancomycin for a total duration of 10 days.  The patient completed her IV antibiotics for hospital-acquired pneumonia, we were not able to wean her oxygen requirements, pulmonary rehab was consulted and they evaluated the patient, she was requiring 2 L on ambulation and 1 L at rest.  Oxygen was arranged at discharge, and patient was discharged on 04/11 in a stable condition.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding concomitant medications, concurrent conditions or medical history. On 14-SEP-2016, the patient was inoculated with ZOSTAVAX at the Pharmacy for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended and the patient subsequently contracted a persistent strain condition of herpes zoster. On 20-SEP-2016, the patient was treated by a healthcare professional and was diagnosed as herpes zoster or shingles. As a direct and proximate result of the ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life, increased risk of premature death, aggravation of pre-existing conditions and activation of latent conditions; lost wages; loss of earnings capacity, and other losses and damages. And pain and suffering, and other damages. At the time of the report, the outcome of the aforementioned adverse events was unknown, excepting for the events of emotional distress and pain that was reported as not resolved. The relatedness assessment between the aforementioned adverse events and ZOSTAVAX was related. The reporter considered the events as serious for the following reasons: Hospitalization, life-threatening, disability and medical significant.
Started as shingles normally do with a rash.  Extreme pain for 8 weeks and still occurring.  Medicated with lidocaine patches, oxycodone, and gabapentin.
Arm swelled from shoulder to down around and past elbow.  Area was very warm and was reddened.  Painful, unable to lift arm, not able to sleep on left side the first night. Ice helped; Aleve did not. Symptoms slowly disappeared over the next four days.  Today being the 4th day, it feels OK but still slightly swollen.
9-29-18 rash on lower legs below knee leg warm to touch, burning and tingle. 10-1-18, ER visit - received antibiotics and prescription antibiotic (doxycycline) 100 mg BID x 10 days. Patient states similar symptoms last year.
I woke up with a sore throat and developed a runny nose and a cough and that was pretty much it. It lasted for about a week. 16th, I was seen by  Health Dept for a COVID test - had rapid and PCR - they were both negative.  February - 2nd week - I had a flare up of my migraines - I had to go to doctor - I had left-sided facial weakness and a diagnosis - Hemiplegic Migraines  - that didn't change my medications. I still get migraines but less frequently.  I had a Kidney infection at end of March - the symptoms started then and in April when I got on medications for that.
I received the shot at 8:30 AM.  No reaction until around 12:30PM when I noticed mild soreness in my arm muscle where I received the shot.  Then around 5:30PM I became progressively fatigued and very mildly feverish.
Information has been received from a licensed practical nurse concerning an 18 year old female who on 20-AUG-2007 was vaccinated intramuscularly with her first dose of GARDASIL (Lot # 658556/1060U). Concomitant therapy included DEPO-PROVERA. On 20-AUG-2007, the patient developed white spots and pain in her upper injection site arm. On 31-OCT-2007, the patient was vaccinated intramuscularly with her second dose of GARDASIL (Lot # 658488/1264U). On 31-OCT-2007, the patient developed white spots and pain in her upper injection site arm. The patient sought unspecified medical attention by mentioning it at an unrelated office visit. The patient is recovering from the white spots and pain. Additional information has been requested. Information has been received from a licensed practical nurse concerning an 18 year old female who in 20-AUG-2007 was vaccinated intramuscularly with her first dose of HPV vaccine (lot # 658556/10600). On 20-AUG-2007, the patient developed white spots and pain in her upper injection sitearm. On31-OCT-2007, the patient was vaccinated intramuscularly with her second dose of HPV (lot # 658488/1264U). On 31-OCT-2007, the patient developed white spots and pain in her upper injection site arm. The patient sought unspecified medical attention by mentioning it an an unrelated office visit. The patient is recovering from the white spots and pain. Additional information has been requested.
FREQUENT URINATION, GROIN PAIN - 2 WEEKS - UTI - PRESCRIBED ANTIBIOTICS
Pt received 4 month set of shots (see below) on Monday 02/09/04.  Parents report that pt did not have any adverse Sx until 11pm of same day, when he woke up and was very fussy and inconsolable.  Pt had minimal sleep and the following day (02/10/2004) in AM he began to cry/scream and could not be comforted.
Event: Right arm is really sore where they put the needle in and has a big knot, size of an egg and it is really hard and has a red rash and itches. was reported as worsened.; has a red rash; itches; has a big knot, size of an egg and it is really hard; Right arm is really sore where they put the needle in; This is a spontaneous report from a contactable consumer (patient, self-reporting). A 74-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection, Lot number: ER8733 and expiration date was not reported), via an unspecified route of administration in right arm on 26Mar2021 at 13:03 (at the age of vaccination 74-years-old) as dose 1, single for COVID-19 immunisation in hospital. On 12Apr2021 she has second shot. The patient's medical history included breast cancer and part of breast removed in 2010. No history of all previous immunization with the Pfizer vaccine considered as suspect. Prior Vaccinations (within 4 weeks) and AE(s) following prior vaccinations was none. Concomitant medications were not reported. On 28Mar2021, right arm was really sore where they put the needle in and has a big knot, size of an egg and it was really hard and a red rash and itches and was reported as worsened. Patient not had any problems with her arm because of it. The patient explained that she had the shot last Friday and it was not a week until tomorrow, but it was really sore where they put the needle in and she has a big knot the size of an egg and it was really hard and red on top, states she guesses that was a rash. At first it starts with itching really bad, and she would rub finger over it, now her whole arm was hurting. She had a rash and it started itching and she thought when it itched it'd be getting better and it started turning red and Sunday formed a knot and the knot kept getting bigger and bigger. States it can be seen when she wears long sleeves. States she tries not to sleep on it because she usually sleeps on right side but she has been sleeping on her back because her arm was sore and itching and she didn't want to cause it to get worse. No investigation assessment. The patient takes pain pills as treatment for her back anyhow and it helped the pain on her arm. The outcome of the adverse event was not recovered.  No follow-up attempts are possible. No further information is expected.
Tingling and itching, mouth and throat swelling, fatigue, muscle pain, headache, lightheadedness, dizziness, tightening of chest and difficulty breathing.
Syncopal episode with resultant head injury and concussion. Following second Pfizer dose given 3/3/2021-intermtittent dizzy spells also started 3/5/2021. Dizzy spells initially worsened in frequency and severity over time (peaking at 11 occurrences per day on 4/1/2021), then slowly started getting less frequent and less severe. Dizzy spells currently occur on avg. 1-2 times per week and are very short lasting spells that are much much less severe. Evaluation by PCP during this time has included lab testing, BP and BS monitoring, EKG, brain MRI, Echocardiogram, 24 hour holter monitoring for 30 days and cosyntropin stimulation testing.
On 3/3/21 I received my second Maderna vaccine on 3/12/21 I felt severe chest and back pains on 3/14/21 intermittently which continued and became more severe.  I was unable to lay down without experiencing excrutiating pain on the right side of my chest.  I was transported via ambulance to Hospital and admitted with a Pulmonary Embolism.  I had no prior history of blood clots.  It was determined that the cause of my blood clots may have been a reaction to the Covid vaccine.  There is no other evidence from all follow up tests and doctor's visits to say otherwise.
She developed severe diffuse pain with insomnia and evidence of autonomic hyperactivity, for weeks after taking the Tdap vaccine.  She has been treated with ATIVAN and ATENOLOL.
8JUL93 MD reported to nurse that pt became ill was taken to hosp & died dx w/Nisseria meningitides menigitis; dx: gram negative shock due to meningococcemia;